Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression.
about
Emerging data on androgen receptor splice variants in prostate cancerTumor Repression of VCaP Xenografts by a Pyrrole-Imidazole Polyamide.AR-v7 protein expression is regulated by protein kinase and phosphatase.Bioluminescence Microscopy as a Method to Measure Single Cell Androgen Receptor Activity Heterogeneous Responses to AntiandrogensThe unidirectional hypoxia-activated prodrug OCT1002 inhibits growth and vascular development in castrate-resistant prostate tumors.Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer.
P2860
Catalytic inhibitors of DNA topoisomerase II suppress the androgen receptor signaling and prostate cancer progression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Catalytic inhibitors of DNA to ...... d prostate cancer progression.
@en
type
label
Catalytic inhibitors of DNA to ...... d prostate cancer progression.
@en
prefLabel
Catalytic inhibitors of DNA to ...... d prostate cancer progression.
@en
P2093
P2860
P356
P1433
P1476
Catalytic inhibitors of DNA to ...... d prostate cancer progression.
@en
P2093
Haolong Li
Martin E Gleave
Xuesen Dong
P2860
P304
20474-20484
P356
10.18632/ONCOTARGET.4105
P407
P577
2015-05-12T00:00:00Z